PortfoliosLab logoPortfoliosLab logo
ANET vs. VRTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ANET vs. VRTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arista Networks, Inc. (ANET) and Vertex Pharmaceuticals Incorporated (VRTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ANET achieves a 24.58% return, which is significantly higher than VRTX's -1.86% return. Over the past 10 years, ANET has outperformed VRTX with an annualized return of 43.12%, while VRTX has yielded a comparatively lower 17.15% annualized return.


ANET

1D
4.37%
1M
16.03%
YTD
24.58%
6M
30.84%
1Y
70.45%
3Y*
57.04%
5Y*
48.31%
10Y*
43.12%

VRTX

1D
-0.03%
1M
-1.80%
YTD
-1.86%
6M
-1.57%
1Y
-3.29%
3Y*
9.16%
5Y*
18.18%
10Y*
17.15%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ANET vs. VRTX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ANET
Arista Networks, Inc.
24.58%18.55%87.73%94.07%-15.58%97.89%42.86%-3.46%-10.56%143.44%
VRTX
Vertex Pharmaceuticals Incorporated
-1.86%12.58%-1.03%40.90%31.50%-7.08%7.94%32.13%10.58%103.42%

Correlation

The correlation between ANET and VRTX is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (10Y)
Calculated over the trailing 10-year period

0.27

Correlation (All Time)
Calculated using the full available price history since Jun 6, 2014

0.27

Over the past year, the correlation between ANET and VRTX has dropped to 0.07 - well below their long-term average of 0.27, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

ANET:

$207.94B

VRTX:

$114.03B

EPS

ANET:

$2.92

VRTX:

$16.87

PE Ratio

ANET:

55.91

VRTX:

26.38

PEG Ratio

ANET:

1.31

VRTX:

2.19

PS Ratio

ANET:

21.42

VRTX:

9.34

PB Ratio

ANET:

15.42

VRTX:

4.31

Total Revenue (TTM)

ANET:

$9.71B

VRTX:

$12.26B

Gross Profit (TTM)

ANET:

$6.17B

VRTX:

$10.57B

EBITDA (TTM)

ANET:

$4.21B

VRTX:

$5.19B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ANET vs. VRTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ANET
ANET Risk / Return Rank: 7878
Overall Rank
ANET Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
ANET Sortino Ratio Rank: 7575
Sortino Ratio Rank
ANET Omega Ratio Rank: 7474
Omega Ratio Rank
ANET Calmar Ratio Rank: 8080
Calmar Ratio Rank
ANET Martin Ratio Rank: 7878
Martin Ratio Rank

VRTX
VRTX Risk / Return Rank: 3737
Overall Rank
VRTX Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
VRTX Sortino Ratio Rank: 3434
Sortino Ratio Rank
VRTX Omega Ratio Rank: 3535
Omega Ratio Rank
VRTX Calmar Ratio Rank: 3838
Calmar Ratio Rank
VRTX Martin Ratio Rank: 3737
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ANET vs. VRTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Arista Networks, Inc. (ANET) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ANETVRTXDifference
Sharpe ratioReturn per unit of total volatility

+1.42

Sortino ratioReturn per unit of downside risk

+1.80

Omega ratioGain probability vs. loss probability

1.24

1.02

+0.22

Calmar ratioReturn relative to maximum drawdown

2.50

-0.14

+2.64

Martin ratioReturn relative to average drawdown

5.20

-0.29

+5.49

ANET vs. VRTX - Sharpe Ratio Comparison

The current ANET Sharpe Ratio is 1.32, which is higher than the VRTX Sharpe Ratio of -0.10. The chart below compares the historical Sharpe Ratios of ANET and VRTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ANET vs. VRTX - Drawdown Comparison

The maximum ANET drawdown since its inception was -52.20%, smaller than the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for ANET and VRTX.


Loading charts...

Drawdown Indicators


ANETVRTXDifference

Max Drawdown

Largest peak-to-trough decline

-52.20%

-91.77%

+39.57%

Max Drawdown (1Y)

Largest decline over 1 year

-28.33%

-23.56%

-4.77%

Max Drawdown (3Y)

Largest decline over 3 years

-50.42%

-29.07%

-21.35%

Max Drawdown (5Y)

Largest decline over 5 years

-50.42%

-29.07%

-21.35%

Max Drawdown (10Y)

Largest decline over 10 years

-52.20%

-41.60%

-10.60%

Current Drawdown

Current decline from peak

-8.15%

-13.90%

+5.75%

Average Drawdown

Average peak-to-trough decline

-15.39%

-37.73%

+22.34%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.60%

11.30%

+2.30%

Volatility

ANET vs. VRTX - Volatility Comparison

Arista Networks, Inc. (ANET) has a higher volatility of 16.62% compared to Vertex Pharmaceuticals Incorporated (VRTX) at 7.47%. This indicates that ANET's price experiences larger fluctuations and is considered to be riskier than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ANETVRTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.62%

7.47%

+9.15%

Volatility (6M)

Calculated over the trailing 6-month period

40.79%

20.71%

+20.08%

Volatility (1Y)

Calculated over the trailing 1-year period

53.57%

34.13%

+19.44%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

47.23%

28.53%

+18.70%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

45.00%

32.82%

+12.18%

Dividends

ANET vs. VRTX - Dividend Comparison

Neither ANET nor VRTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ANET vs. VRTX - Financials Comparison

This section allows you to compare key financial metrics between Arista Networks, Inc. and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


1.00B1.50B2.00B2.50B3.00B20222023202420252026
2.71B
2.99B
(ANET) Total Revenue
(VRTX) Total Revenue
Values in USD except per share items

ANET vs. VRTX - Profitability Comparison

The chart below illustrates the profitability comparison between Arista Networks, Inc. and Vertex Pharmaceuticals Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

55.0%60.0%65.0%70.0%75.0%80.0%85.0%90.0%20222023202420252026
61.9%
86.9%
Portfolio components
ANET - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Arista Networks, Inc. reported a gross profit of 1.68B and revenue of 2.71B. Therefore, the gross margin over that period was 61.9%.

VRTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Vertex Pharmaceuticals Incorporated reported a gross profit of 2.59B and revenue of 2.99B. Therefore, the gross margin over that period was 86.9%.

ANET - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Arista Networks, Inc. reported an operating income of 1.16B and revenue of 2.71B, resulting in an operating margin of 42.7%.

VRTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Vertex Pharmaceuticals Incorporated reported an operating income of 1.14B and revenue of 2.99B, resulting in an operating margin of 38.1%.

ANET - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Arista Networks, Inc. reported a net income of 1.02B and revenue of 2.71B, resulting in a net margin of 37.8%.

VRTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Vertex Pharmaceuticals Incorporated reported a net income of 1.03B and revenue of 2.99B, resulting in a net margin of 34.5%.


Frequently Asked Questions


ANET and VRTX have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ANET has higher volatility (16.62%) compared to VRTX (7.47%). In terms of maximum drawdown, ANET dropped -52.20% vs VRTX's -91.77%.

ANET currently has the higher Sharpe Ratio (1.32 vs -0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ANET and VRTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer